Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Sci Adv ; 9(49): eadj6187, 2023 Dec 08.
Article in English | MEDLINE | ID: mdl-38064562

ABSTRACT

While most research and treatments for multiple sclerosis (MS) focus on autoimmune reactions causing demyelination, it is possible that neurodegeneration precedes the autoimmune response. Hence, glutamate receptor antagonists preventing excitotoxicity showed promise in MS animal models, though blocking glutamate signaling prevents critical neuronal functions. This study reports the discovery of a small molecule that prevents AMPA-mediated excitotoxicity by targeting an allosteric binding site. A machine learning approach was used to screen for small molecules targeting the AMPA receptor GluA2 subunit. The lead candidate has potent effects in restoring neurological function and myelination while reducing the immune response in experimental autoimmune encephalitis and cuprizone MS mouse models without affecting basal neurotransmission or learning and memory. These findings facilitate development of a treatment for MS with a different mechanism of action than current immune modulatory drugs and avoids important off-target effects of glutamate receptor antagonists. This class of MS therapeutics could be useful as an alternative or complementary treatment to existing therapies.


Subject(s)
Multiple Sclerosis , Mice , Animals , alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid/pharmacology , Excitatory Amino Acid Antagonists/pharmacology , Receptors, AMPA , Neurons/metabolism
2.
J Chem Inf Model ; 58(5): 916-932, 2018 05 29.
Article in English | MEDLINE | ID: mdl-29698607

ABSTRACT

Undetected overfitting can occur when there are significant redundancies between training and validation data. We describe AVE, a new measure of training-validation redundancy for ligand-based classification problems, that accounts for the similarity among inactive molecules as well as active ones. We investigated seven widely used benchmarks for virtual screening and classification, and we show that the amount of AVE bias strongly correlates with the performance of ligand-based predictive methods irrespective of the predicted property, chemical fingerprint, similarity measure, or previously applied unbiasing techniques. Therefore, it may be the case that the previously reported performance of most ligand-based methods can be explained by overfitting to benchmarks rather than good prospective accuracy.


Subject(s)
Drug Discovery/methods , Machine Learning , Benchmarking , Ligands
3.
Nucleic Acids Res ; 40(Database issue): D428-33, 2012 Jan.
Article in English | MEDLINE | ID: mdl-22067445

ABSTRACT

The patent literature is a rich catalog of biologically relevant chemicals; many public and commercial molecular databases contain the structures disclosed in patent claims. However, patents are an equally rich source of metadata about bioactive molecules, including mechanism of action, disease class, homologous experimental series, structural alternatives, or the synthetic pathways used to produce molecules of interest. Unfortunately, this metadata is discarded when chemical structures are deposited separately in databases. SCRIPDB is a chemical structure database designed to make this metadata accessible. SCRIPDB provides the full original patent text, reactions and relationships described within any individual patent, in addition to the molecular files common to structural databases. We discuss how such information is valuable in medical text mining, chemical image analysis, reaction extraction and in silico pharmaceutical lead optimization. SCRIPDB may be searched by exact chemical structure, substructure or molecular similarity and the results may be restricted to patents describing synthetic routes. SCRIPDB is available at http://dcv.uhnres.utoronto.ca/SCRIPDB.


Subject(s)
Chemical Phenomena , Databases, Factual , Patents as Topic , Molecular Structure
4.
J Mol Graph Model ; 29(1): 93-101, 2010 Aug 24.
Article in English | MEDLINE | ID: mdl-20713281

ABSTRACT

Ligand-based active site alignment is a widely adopted technique for the structural analysis of protein-ligand complexes. However, existing tools for ligand alignment treat the ligands as rigid objects even though most biological ligands are flexible. We present LigAlign, an automated system for flexible ligand alignment and analysis. When performing rigid alignments, LigAlign produces results consistent with manually annotated structural motifs. In performing flexible alignments, LigAlign automatically produces biochemically reasonable ligand fragmentations and subsequently identifies conserved structural motifs that are not detected by rigid alignment.


Subject(s)
Catalytic Domain , Sequence Alignment/methods , Software , Amino Acid Sequence , Heme/chemistry , Heme/metabolism , Ligands , Molecular Sequence Data , NAD/chemistry , NAD/metabolism , Sequence Homology, Amino Acid
SELECTION OF CITATIONS
SEARCH DETAIL
...